Zurcher Kantonalbank (Zurich Cantonalbank) X Biotech Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$34.1 Billion
Q4 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 09, 2022	SELL	$5.13 - $9.2 $10,885 - $19,522	-2,122 Closed	0 $0
Q2 2020 Jul 28, 2020	BUY	$10.39 - $16.07 $22,047 - $34,100	2,122 New	2,122 $29,000

Others Institutions Holding XBIT

# of Institutions

Shares Held

4.9M

Call Options Held

Put Options Held

Black Rock Inc. New York, NY

1.13M
Shares

$3.79 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.06M
Shares

$3.56 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

452K
Shares

$1.51 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

281K
Shares

$938,603
0.0% of portfolio
Ubs Asset Management Americas Inc Chicago, IL

254K
Shares

$847,591
0.0% of portfolio

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $102M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account